Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis

Nephrology Dialysis Transplantation

Volumn 24, Issue 1, 2009, Pages 267-271

  Burkhardt, Olaf ^a   Hafer, Carsten ^a   Langhoff, Anita ^a   Kaever, Volkhard ^a   Kumar, Vipul ^b   Welte, Tobias ^a   Haller, Hermann ^a   Fliser, Danilo ^a   Kielstein, Jan T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Ertapenem; ICU patients; Pharmacokinetics; Renal insufficiency; Renal replacement therapy

Indexed keywords

ERTAPENEM; POLYSULFONE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BINDING SITE; BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIALYSATE; DRUG BLOOD LEVEL; DRUG CLEARANCE; EXTENDED DAILY DIALYSIS; FEMALE; HUMAN; KIDNEY FUNCTION; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CRITICAL ILLNESS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 58049192974     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn472     Document Type: Article

References (17)

1. Burkhardt O, Derendorf H, Welte T. Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice. Expert Opin Pharmacother 2007; 8: 237-256
2. Majumdar AK, Musson DG, Birk KL et al. Pharmacokinetics of ertapenem in healthy young volunteers. Antimicrob Agents Chemother 2002; 46: 3506-3511
3. Musson DG, Birk KL, Kitchen CJ et al. Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 783: 1-9
4. Mistry GC, Majumdar AK, Swan S et al. Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis. J Clin Pharmacol 2006; 46: 1128-1138
5. Fiaccadori E, Maggiore U, Rotelli C et al. Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation. Nephrol Dial Transplant 2006; 21: 1402-1406
6. Fliser D, Kielstein JT. Technology insight: treatment of renal failure in the intensive care unit with extended dialysis. Nat Clin Pract Nephrol 2006; 2: 32-39
7. Burkhardt O, Joukhadar C, Traunmuller F et al. Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis. J Antimicrob Chemother 2008; 61: 224-225
8. Czock D, Husig-Linde C, Langhoff A et al. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clin J Am Soc Nephrol 2006; 1: 1263-1268
9. Fiaccadori E, Maggiore U, Rotelli C et al. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Crit Care Med 2004; 32: 2437-2442
10. Kielstein JT, Czock D, Schopke T et al. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis. Crit Care Med 2006; 34: 51-56
11. Kielstein JT, Kretschmer U, Ernst T et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 2004; 43: 342-349
12. Dhondt AW, Vanholder RC, De Smet RV et al. Studies on dialysate mixing in the GENIUS® single-pass batch system for hemodialysis therapy. Kidney Int 2003; 63: 1540-1547
13. Koal T, Deters M, Resch K et al. Quantification of the carbapenem antibiotic ertapenem in human plasma by a validated liquid chromatography-mass spectrometry method. Clin Chim Acta 2006; 364: 239-245
14. Burkhardt O, Brunner M, Schmidt S et al. Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis. J Antimicrob Chemother 2006; 58: 632-636
15. Burkhardt O, Kumar V, Katterwe D et al. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration. J Antimicrob Chemother 2007; 59: 277-284
16. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818
17. Eloot S, Van Biesen W, Dhondt A et al. Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 2007; 73: 765-770